• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

40至60岁健康女性低骨量的风险因素:文献系统综述

Risk factors for low bone mass in healthy 40-60 year old women: a systematic review of the literature.

作者信息

Waugh E J, Lam M-A, Hawker G A, McGowan J, Papaioannou A, Cheung A M, Hodsman A B, Leslie W D, Siminoski K, Jamal S A

机构信息

Osteoporosis Research Program, Women's College Hospital, Toronto, ON, Canada.

出版信息

Osteoporos Int. 2009 Jan;20(1):1-21. doi: 10.1007/s00198-008-0643-x. Epub 2008 Jun 4.

DOI:10.1007/s00198-008-0643-x
PMID:18523710
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5110317/
Abstract

UNLABELLED

Based on a systematic review of the literature, only low body weight and menopausal status can be considered with confidence, as important risk factors for low BMD in healthy 40-60 year old women. The use of body weight to identify high risk women may reduce unnecessary BMD testing in this age group.

INTRODUCTION

BMD testing of perimenopausal women is increasing but may be unnecessary as fracture risk is low. Appropriate assessment among younger women requires identification of risk factors for low BMD specific to this population.

METHODS

We conducted a systematic literature review of risk factors for low BMD in healthy women aged 40-60 years. Articles were retrieved from six databases and reviewed for eligibility and methodological quality. A grade for overall strength of evidence for each risk factor was assigned.

RESULTS

There was good evidence that low body weight and post-menopausal status are risk factors for low BMD. There was good or fair evidence that alcohol and caffeine intake, and reproductive history are not risk factors. There was inconsistent or insufficient evidence for the effect of calcium intake, physical activity, smoking, age at menarche, history of amenorrhea, family history of OP, race and current age on BMD.

CONCLUSIONS

Based on current evidence in Caucasians, we suggest that, in healthy women aged 40-60 years, only those with a low body weight (< 70 kg) be selected for BMD testing. Further research is necessary to determine optimal race-specific discriminatory weight cut-offs and to evaluate the risk factors for which there was inconclusive evidence.

摘要

未标注

基于对文献的系统综述,在健康的40 - 60岁女性中,只有低体重和绝经状态可被确定为低骨密度的重要风险因素。使用体重来识别高危女性可能会减少该年龄组不必要的骨密度检测。

引言

围绝经期女性的骨密度检测正在增加,但由于骨折风险较低,可能并无必要。对年轻女性进行适当评估需要识别该人群特有的低骨密度风险因素。

方法

我们对40 - 60岁健康女性低骨密度的风险因素进行了系统的文献综述。从六个数据库检索文章,并对其资格和方法学质量进行审查。为每个风险因素的总体证据强度评定等级。

结果

有充分证据表明低体重和绝经后状态是低骨密度的风险因素。有充分或中等证据表明酒精和咖啡因摄入量以及生殖史不是风险因素。关于钙摄入量、身体活动、吸烟、初潮年龄、闭经史、骨质疏松家族史、种族和当前年龄对骨密度的影响,证据不一致或不足。

结论

基于目前对白种人的证据,我们建议,在40 - 60岁的健康女性中,仅选择那些体重低(< 70 kg)的女性进行骨密度检测。有必要进一步研究以确定针对不同种族的最佳区分体重临界值,并评估证据尚无定论的风险因素。

相似文献

1
Risk factors for low bone mass in healthy 40-60 year old women: a systematic review of the literature.40至60岁健康女性低骨量的风险因素:文献系统综述
Osteoporos Int. 2009 Jan;20(1):1-21. doi: 10.1007/s00198-008-0643-x. Epub 2008 Jun 4.
2
Effectiveness and safety of vitamin D in relation to bone health.维生素D对骨骼健康的有效性与安全性。
Evid Rep Technol Assess (Full Rep). 2007 Aug(158):1-235.
3
Long-term hormone therapy for perimenopausal and postmenopausal women.围绝经期和绝经后女性的长期激素治疗
Cochrane Database Syst Rev. 2017 Jan 17;1(1):CD004143. doi: 10.1002/14651858.CD004143.pub5.
4
Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis.糖皮质激素性骨质疏松症:一项系统评价与成本效用分析
Health Technol Assess. 2007 Mar;11(7):iii-iv, ix-xi, 1-231. doi: 10.3310/hta11070.
5
Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.利塞膦酸钠用于绝经后妇女骨质疏松性骨折的一级和二级预防。
Cochrane Database Syst Rev. 2022 May 3;5(5):CD004523. doi: 10.1002/14651858.CD004523.pub4.
6
A systematic review of the effectiveness of strategies for reducing fracture risk in children with juvenile idiopathic arthritis with additional data on long-term risk of fracture and cost of disease management.对降低幼年特发性关节炎患儿骨折风险策略的有效性进行系统评价,并提供关于骨折长期风险和疾病管理成本的额外数据。
Health Technol Assess. 2008 Mar;12(3):iii-ix, xi-xiv, 1-208. doi: 10.3310/hta12030.
7
Interventions targeted at women to encourage the uptake of cervical screening.针对女性的干预措施,以鼓励她们接受宫颈癌筛查。
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3.
8
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
9
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
10
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.

引用本文的文献

1
The Impact of Body Mass Index and Benign Prostatic Hyperplasia on Bone Health of Middle-Aged and Older Men.体重指数和良性前列腺增生对中老年男性骨骼健康的影响。
Obes Sci Pract. 2025 Jan 8;11(1):e70037. doi: 10.1002/osp4.70037. eCollection 2025 Feb.
2
From Evidence to Practice: A Comprehensive Analysis of Side Effects in Synthetic Anti-Depressant Therapy.从证据到实践:合成抗抑郁药治疗副作用的综合分析
Curr Drug Saf. 2025;20(2):120-147. doi: 10.2174/0115748863301630240417071353.
3
New Emerging Aspect of Herbal Extracts for the Treatment of Osteoporosis: Overview.草药提取物治疗骨质疏松症的新进展:概述。
Curr Rheumatol Rev. 2024;20(4):361-372. doi: 10.2174/0115733971273691231121131455.
4
The clinician's guide to prevention and treatment of osteoporosis.临床医生骨质疏松症防治指南。
Osteoporos Int. 2022 Oct;33(10):2049-2102. doi: 10.1007/s00198-021-05900-y. Epub 2022 Apr 28.
5
Reference values for bone density and bone mineral content from 5 to 80 years old in a province of Chile.智利一省 5 至 80 岁人群骨密度和骨矿物质含量参考值。
PeerJ. 2022 Mar 23;10:e13092. doi: 10.7717/peerj.13092. eCollection 2022.
6
Risk Factors Analysis of Bone Mineral Density Based on Lasso and Quantile Regression in America during 2015-2018.2015-2018 年美国基于套索和分位数回归的骨密度风险因素分析。
Int J Environ Res Public Health. 2021 Dec 30;19(1):355. doi: 10.3390/ijerph19010355.
7
The Role of Pediatric Nutrition as a Modifiable Risk Factor for Precocious Puberty.儿童营养作为性早熟可改变风险因素的作用。
Life (Basel). 2021 Dec 7;11(12):1353. doi: 10.3390/life11121353.
8
The therapeutic potential of mesenchymal stem cells in treating osteoporosis.间充质干细胞在治疗骨质疏松症中的治疗潜力。
Biol Res. 2021 Dec 20;54(1):42. doi: 10.1186/s40659-021-00366-y.
9
Self-emulsified annatto tocotrienol improves bone histomorphometric parameters in a rat model of oestrogen deficiency through suppression of skeletal sclerostin level and RANKL/OPG ratio.自乳化姜黄素生育三烯酚通过抑制骨骼硬化素水平和 RANKL/OPG 比值改善去势雌鼠模型的骨组织形态计量学参数。
Int J Med Sci. 2021 Sep 9;18(16):3665-3673. doi: 10.7150/ijms.64045. eCollection 2021.
10
Characteristics of incidence hip fracture cases in older adults participating in the longitudinal AGES-Reykjavik study.参与纵向 AGES-Reykjavik 研究的老年髋部骨折病例的发病特征。
Osteoporos Int. 2021 Feb;32(2):243-250. doi: 10.1007/s00198-020-05567-x. Epub 2020 Aug 18.

本文引用的文献

1
Performance of osteoporosis risk assessment tools in postmenopausal women aged 45-64 years.45至64岁绝经后女性骨质疏松风险评估工具的性能
Osteoporos Int. 2005 Aug;16(8):921-7. doi: 10.1007/s00198-004-1775-2. Epub 2004 Nov 20.
2
Educational level and osteoporosis risk in postmenopausal Chinese women.中国绝经后女性的教育水平与骨质疏松症风险
Am J Epidemiol. 2005 Apr 1;161(7):680-90. doi: 10.1093/aje/kwi047.
3
Amenorrhea and bone health in adolescents and young women.青少年及青年女性的闭经与骨骼健康
Curr Opin Obstet Gynecol. 2003 Oct;15(5):377-84. doi: 10.1097/00001703-200310000-00005.
4
Disordered eating, menstrual irregularity, and bone mineral density in female runners.女性跑步者的饮食失调、月经不规律与骨密度
Med Sci Sports Exerc. 2003 May;35(5):711-9. doi: 10.1249/01.MSS.0000064935.68277.E7.
5
2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada.2002年加拿大骨质疏松症诊断与管理临床实践指南。
CMAJ. 2002 Nov 12;167(10 Suppl):S1-34.
6
A longitudinal study of bone density in midlife women.中年女性骨密度的纵向研究。
Health Care Women Int. 2002 Sep-Nov;23(6-7):678-91. doi: 10.1080/07399330290107421.
7
Osteoporosis prevention, diagnosis, and therapy.骨质疏松症的预防、诊断与治疗。
NIH Consens Statement. 2000;17(1):1-45.
8
Evaluation of decision rules for referring women for bone densitometry by dual-energy x-ray absorptiometry.通过双能X线吸收法为女性进行骨密度测定的转诊决策规则评估。
JAMA. 2001 Jul 4;286(1):57-63. doi: 10.1001/jama.286.1.57.
9
Current methods of the US Preventive Services Task Force: a review of the process.美国预防服务工作组的当前方法:过程回顾
Am J Prev Med. 2001 Apr;20(3 Suppl):21-35. doi: 10.1016/s0749-3797(01)00261-6.
10
Family history of appendicular fracture and risk of osteoporosis: a population-based study.阑尾骨折家族史与骨质疏松症风险:一项基于人群的研究。
Osteoporos Int. 1999;10(2):161-6. doi: 10.1007/s001980050211.